ArticleCell stem cell2018
Meddling with METTLs in Normal and Leukemia Stem Cells.
Article in Cell stem cell, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- The metabolic profiles of cancer stem cells.Stem cell research & therapy · 2026Review
- Reprogramming of RNA m6A Modification Is Required for Acute Myeloid Leukemia Development.Genomics, proteomics & bioinformatics · 2025Article
- Epigenetic modifications in hematopoietic ecosystem: a key tuner from homeostasis to acute myeloid leukemia.Blood science (Baltimore, Md.) · 2024Review
- N6-methyladenosine RNA modifications: a potential therapeutic target for AML.Annals of hematology · 2024Review
- Multi-dimensional structural footprint identification for the design of potential scaffolds targeting METTL3 in cancer treatment from natural compounds.Journal of molecular modeling · 2023Article
- Bibliometric analysis of METTL3: Current perspectives, highlights, and trending topics.Open life sciences · 2023Review
- RNA Modifications in Hematologic Malignancies.Cancer treatment and research · 2023Article
- Functions, mechanisms, and therapeutic implications of METTL14 in human cancer.Journal of hematology & oncology · 2022Review
- RNA methylation in mammalian development and cancer.Cell biology and toxicology · 2021Review
- Review
- RNA mFrontiers in cell and developmental biology · 2021Review
- RNAFrontiers in oncology · 2021Review
- N6-methyladenine modification in noncoding RNAs and its function in cancer.Biomarker research · 2020Review
- Upregulated METTL3 in nasopharyngeal carcinoma enhances the motility of cancer cells.The Kaohsiung journal of medical sciences · 2020Article
- Epitranscriptomics in Normal and Malignant Hematopoiesis.International journal of molecular sciences · 2020Review
- Roles of METTL3 in cancer: mechanisms and therapeutic targeting.Journal of hematology & oncology · 2020Review
Corrections and comments
- Comment onThe N2017
- Comment on
- Comment on
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Three recent studies independently identified the m
Indexed as
Identifiers
29395048What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.